Date post: | 23-Dec-2015 |
Category: |
Documents |
Upload: | bertram-barton |
View: | 215 times |
Download: | 0 times |
The Male The Male Biological ClockBiological Clock
John L. Frattarelli, M.D., FACOGJohn L. Frattarelli, M.D., FACOGReproductive Medicine Associates of New Reproductive Medicine Associates of New
JerseyJersey
Male Menopause/Adrenopause?
– Decreased • Testosterone levels
• Libido
• Hair
• Muscle mass
• Strength
– Increased• Weight
• Erectile dysfunction
• Infertility
• Depression
• Cholesterol
As men age:As men age:
Male InfertilityMale Infertility
• 30-40 % infertile couples30-40 % infertile couples
• Etiologies:Etiologies:– stress, fever, infections, drugs, work/environment stress, fever, infections, drugs, work/environment
hazards, agehazards, age
• Semen analysisSemen analysis– spermatogenesis 74 daysspermatogenesis 74 days– 14 days to pass through testis14 days to pass through testis
Male Infertility
31.716.6
98.9
8.55.8
54.2
2.31.5
6.5
0 5 10 15 20 25 30 35
Idiopathic
Varicocele
Infection
Hypogonadism
Cryptorchidism
Malformation
Systemic
Immunologic
Tumor
Obstruction
Other
Hum Reprod Update 1999; 5(2): 120
Percent (%)
AGE?AGE?
Semen AnalysisSemen Analysis• VolumeVolume >2.0 cc>2.0 cc• pHpH 7.2 - 7.87.2 - 7.8• ConcentrationConcentration 20 mil/mL20 mil/mL• TotalTotal >40 mil>40 mil• MotilityMotility >50% forward/25% rapid>50% forward/25% rapid• MorphologyMorphology >30%*>30%*
>14%**>14%**• WBCWBC <1 mil/mL<1 mil/mL
*WHO, 1992*WHO, 1992**Kruger Strict Criteria, 1999**Kruger Strict Criteria, 1999
Sperm Density
0
5
10
15
20
25
Per
cent
(%
)
0-20
21-4
041
-60
61-8
0
81-1
00
101-
120
121-
140
141-
160
>160
Million/mL
Fertile Infertile
J Urol 1951; 66(3): 436
Sperm Morphology features as a Prognostic Factor in IVF
0
25
50
75
100
Per
cent
(%
)
0-14% 15-30% 31-45% 46-60%
Morphology (%)
Fert/egg0 FertPR/retPR/ET
Kruger TF et al. Fertil Steril 1986; 46: 1118
Effect of male age on sperm quality and fertilityKidd et al. Fertil Steril 2001
• Review of the published literature from 1980-1999• Volume
– Decrease 3-30% from age 30 to 50• Seminal vesicle and prostate changes
• Concentration– No change
• No control for abstinence• Motility
– Decrease 3-37% from age 30 to 50• Prostate and epididymal changes
• Morphology– Decrease 4-22% from age 30 to 50
• Germinal epithelium and epididymal changes• Pregnancy rates
– Confounded by age but a trend for a 38% decrease from age 30 to 50
Male Factor Treatment Pregnancy rate results from RCT
• Bromocriptine– 4 trials– OR 0.7, 95% CI 0.15-3.24
• Androgen therapy– 11 trials, n=930– OR 1.1, 95% CI 0.75-1.61
• Clomiphene citrate– 10 trials, n=738– OR 1.56, 95% CI 0.99-2.19
Cochrane Reviews 2003
IUIIUI• Need 1 million motile Need 1 million motile
spermsperm
• Prefer > 5 million Prefer > 5 million motilemotile
• Little benefit >10 Little benefit >10 million motilemillion motile
• IUI vs Timed CoitusIUI vs Timed Coitus
– Meta-analysisMeta-analysis
– 17 RCT, n=3662 cycles17 RCT, n=3662 cycles• Natural cycleNatural cycle
– OR 2.43 (1.5-3.8)OR 2.43 (1.5-3.8)• COHCOH
– OR 2.14 (1.3-3.5)OR 2.14 (1.3-3.5)
– Common OR for fecundity Common OR for fecundity = 2.37 = 2.37
• 95% CI 1.43-3.9095% CI 1.43-3.90
Cochrane Reviews 2003
Evidence for declining fertility in older men
• 8515 planned pregnancies• Large population study questionnaire• Gestations >24 weeks
Ford et al. Hum Reprod, 2000Ford et al. Hum Reprod, 2000
0
20
40
60
80
100
Preg
nanc
y ra
te
<25 25-29 30-34 35-39 40>
6-months6-months
Male ageMale ageFemale ageFemale age
0
20
40
60
80
100
Preg
nanc
y ra
te
<25 25-29 30-34 35-39 40>
12-months12-months
Evidence for declining fertility in older menFord et al. Hum Reprod, 2000Ford et al. Hum Reprod, 2000
00.20.40.60.8
11.2
Odds
ratio
<25 25-29 30-34 35-39 40>
Male ageMale ageFemale ageFemale age
12-months12-months• Adjusted odds
ratios– Adjusted for
partner age, BMI, smoking, passive smoke, education, duration of cohabitation, duration of OC use, alcohol consumption
Outcome rates and male age in 1023 donor oocyte cycles.
Frattarelli in press, Frattarelli in press, 20072007
0
20
40
60
80
100
Rat
e (%
)
Implantation Pregnancy Loss Live Birth
overall< 36 years36-40 years41-45 years46-50 years51-55 years> 55 years
Outcome rates and male age in 1023 donor oocyte cycles.
Frattarelli in press, Frattarelli in press, 20072007
0
20
40
60
80
100
Rat
e (%
)
Implantation Pregnancy Loss Live Birth Blast
< 50 years> 50 years
P<0.05P<0.05
P<0.05P<0.05
P<0.05P<0.05
Couple age and Miscarriage rate
• N=3174
• Data from European Multicenter Study on Infertilty and Subfertility 1991-1993
• Combined male and female ages to make a single categorical variable for multiple logistic regression
0
2
4
6
8
10
Adju
sted
OR
20-29 30-34 35-39 40-64
20-29
30-34
35-44
Paternal age Mat
erna
l age
Mat
erna
l age
de La Rochebrochard and Thonneau, Hum Reprod 2002de La Rochebrochard and Thonneau, Hum Reprod 2002
Outcome rates and male age in 1023 donor oocyte cycles.
Frattarelli in press, Frattarelli in press, 20072007
0
5
10
15
20
25
30
Los
s ra
te (
%)
<36 36-40 41-45 46-50 51-55 >55
Male age
P<0.05P<0.05
24.4
41.5
0
5
10
15
20
25
30
35
40
45
Per
cen
t (%
)
Loss rate
<50 years>50 years
P<0.05P<0.05
The impact of paternal age on aneuploidy rates in first trimester losses
26.1 25
34.6
0
10
20
30
40
Rat
e (%
)
Controls Paternal age <40 Paternal age >40
• Controls = IVF patients using autologous oocytes (n=23)– Mean female age = 28.7 ± 1.1– Mean male age = 33.7 ± 7.6
• Donor oocyte group (n=50)– Mean donor age = 27.8 ± 3.9– Mean female age = 39.6 ± 5.0– Mean male age = 41.5 ± 6.8
Frattarelli in press, Frattarelli in press, 20072007
Early hints at the link between paternal age and
birth defects
• 1912-Dr. Weinberg– Achondroplasia more often in younger siblings
• Dr. Penrose– Paternal age associated with de novo AD mutations
• Now >20 disorders associated with paternal age– Alpert, Crouzon, Pfeiffer, Marfan, Achrondoplasia,
neurofibromatosis, osteogenesis imperfecta
Meiosis vs Mitosis
• Women have ~24 divisions in the cells that give rise to their eggs
• Men have >30 rounds of mitosis prior to puberty– About 23 replications
per year
Spermatogenesis
• ~23 replications per year
• Age 30– 380 mitotic divisions
• Age 40– 610 mitotic divisions
• Age 50– 840 mitotic divisions
Primary Spermatocyte
Secondary Spermatocyte
Spermatids
Normal Sperm
n
2n
n
nn nn
nn n
n
Meiosis I
Meiosis II
Male Infertility
• Infertile males with oligospermia or azoospermia (n = 9766)
– 5.8% incidence of chromosomal abnormalities• 4.2% sex chromosome• 1.5% autosome
– Baseline fertile males: 0.5%
Johnson, Fertil Steril 1998Johnson, Fertil Steril 1998
Karyotypic Abnormalities
• Frequency is inversely proportional to sperm concentration
• Most common anomaly is Klinefelter syndrome– atrophic hyalinized testes
depleted of germ cells
0
5
10
15
Kar
ytyp
e ab
nrom
ality
(%)
Sharlip et al. Fertil Steril 2002
Male Infertility• Cytogenetic surveys of
oligospermic and azoospermic males
– oligo-: 4.6 % with cytogenetic abnormalities
• 1.6 % sex chromosomal• 3.0 % autosomal
– azoo-: 13.7 % with cytogenetic abnormalities
• 12.6 % sex chromosomal• 1.1 % autosomal
0
2
4
6
8
10
12
14
% c
ytog
enet
ic
abno
rmal
itie
sOligo- Azoo-
DNA damage in sperm
• N=66
• Ages 20-57
• Gradual increased in DNA damage – Most pronounced after age 35
• ?Apoptosis decreases with age?
Singh et al. Fertil Steril 2003Singh et al. Fertil Steril 2003
Influence of Paternal Age on Down Syndrome
• Incidence from 1983-1997
• N =3419 cases• NY state DOH
congenital malformations registry
• No paternal influence until >35 years
• Paternal age contributes 50% risk
0
200
400
600
800
<24 25-29 30-34 35-39 40>
Rat
e pe
r 10
0,00
0 B
irth
s
Maternal Age uncorrected for Paternal AgeMaternal Age CORRECTED for Paternal Age
Fisch et al. J Urol 2003Fisch et al. J Urol 2003
SchizophreniaPaternal Age Group
RR (95% CI)
<24 1
25-29 1.14 (0.8-1.5)
30-34 1.42 (1.0-2.0)
35-39 1.64 (1.1-2.4)
40-44 1.73 (1.1-2.7)
45-49 2.02 (1.2-3.5)
>50 2.96 (1.6-5.5)
Maternal Age Group
RR (95% CI)
<24 1
25-29 1.01 (0.8-1.3)
30-34 1.10 (0.8-1.4)
35-39 1.2 (0.8-1.7)
>40 1.2 (0.8-1.7)
-Israeli psychiatric registry-Israeli psychiatric registry-Controlled for age of other parent-Controlled for age of other parent-Also for sex, ethnicity, and education-Also for sex, ethnicity, and education
Malaspina et al. Arch Gen Psychiatry 2001Malaspina et al. Arch Gen Psychiatry 2001
Risk at paternal age of 40 Risk at paternal age of 40 ~ 1/110~ 1/110Similar to the female risk Similar to the female risk of Downs at the same ageof Downs at the same age
2% incidence of schizophrenia for 2% incidence of schizophrenia for males >50 yearsmales >50 years
Yp
Yq
SRYRPS4YZFY
YRRM1
YRRM1, YRRM2DAZ AZF region
Yq12
Yq11Yq11
PAR1
MicrodeletionsMicrodeletions
• Yq11 microdeletionsYq11 microdeletions
– 10-15% azo- / severely 10-15% azo- / severely oligozoospermic menoligozoospermic men
– AZF =azoospermia factor
– AZFa to AZFc in the Yq11.21-23 region
– To small to be detected by To small to be detected by karyotypingkaryotyping
– Can be detected by PCRCan be detected by PCR
Brandell et al. Hum Repro 1998
Yp
Yq
SRYRPS4YZFY
YRRM1
YRRM1, YRRM2DAZ AZF region
Yq12
Yq11Yq11
PAR1
Microdeletions
• N=5000 infertile males screened for Y-chromosome mutations in the AZF region
– 8.2% infertile males– 0.4% fertile males
Foresta et al. Endo Rev 2001
8.2
0.4
0
5
10
% A
ZF
del
etio
n
Infertile Fertile
Intracytoplasmic Sperm Injection (ICSI)
ICSI-Derived Offspring
• Of concern because of increased sperm aneuploidy in OAT males
• 1% incidence of sex chromosome aneuploidy in ICSI conceptions– 0.14 % - 0.19 % baseline
(non-ICSI)
– ? Unidentified Klinefelter’s mosaics
• Consider karyotyping all infertile males?
• Consider prenatal diagnosis for all ICSI-derived pregnancies?
5 year follow up of ICSI Children• Examination at 5 years of age• Matched to spontaneous conception controls
– Maternal age– Gender– Child age– Same centers
• Assessment– Growth– General health– Chronic illnesses– Surgical intervention– Neurological development
• Results– ICSI children had more surgical interventions (13% vs 10.5%)– Otherwise equivalent outcomes
Bonduelle et al Reprod Biomed Online 2004: 91-101
Summary
• Male aging– Decreased spermatogenesis– Decreased fertility– Increased miscarriage risk– Increased aneuploidy rates
Recommendations
• Karyotyping should be strongly considered– translocations, sex chromosome aneuploidy,
gonadal mosaicism
• Screening for AZF microdeletions• Preimplantation genetic screening• Amniocentesis/CVS• Genetic Counseling• Donor sperm